Evidence map›Paper›PMID 26423598›Full record

ArticleThe British journal of radiology2015

Triaxial system in bronchial arterial embolization for haemoptysis using N-butyl-2-cyanoacrylate.

Masashi Shimohira, Takeshi Hashimoto, Saori Abematsu, Takuya Hashizume, Motoo Nakagawa, Yoshiyuki Ozawa, Keita Sakurai, Yuta Shibamoto

Abstract read
In one paragraph

Article in The British journal of radiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Masashi Shimohira1 Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Takeshi Hashimoto2 Department of Radiology, Kouseikai Hospital, Toyohashi, Japan.
Saori Abematsu3 Department of Radiology, Shizuoka City Shimizu Hospital, Shizuoka, Japan.
Takuya Hashizume1 Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Motoo Nakagawa1 Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Yoshiyuki Ozawa1 Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Keita Sakurai1 Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Yuta Shibamoto1 Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Nagoya City University · JPShizuoka City Shimizu Hospital · JPToyohashi Municipal Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe application of bronchial artery embolization (BAE) using N-butyl-2-cyanoacrylate (NBCA) for haemoptysis was recently reported to be useful. A triple co-axial (triaxial) system consisting of a 4-Fr catheter, 2.7-Fr microcatheter and 1.9-Fr no-taper microcatheter has been developed. The aim of the present study was to evaluate the usefulness of the triaxial system in BAE using NBCA.

methods12 patients with haemoptysis, 8 males and 4 females with a median age of 64 years (range, 49-88 years), underwent BAE between August 2012 and October 2014. Medical records and images were reviewed, and the technical success rate, clinical success rate, haemoptysis-free rate and complications were evaluated. Technical success was defined as the complete cessation of the target artery as confirmed by digital subtraction angiography, whereas clinical success was defined as the cessation of haemoptysis within 24 h of BAE. Recurrent haemoptysis was defined as a total of >30 ml of bleeding per day.

resultsThe target artery was embolized successfully in all patients, and the technical success rate was 100% (12/12). The cessation of haemoptysis was achieved in 11 out of 12 patients within 24 h, and thus, the clinical success rate was 92% (11/12). The 6-, 12- and 24-month haemoptysis-free rates were 89%, 89% and 76%, respectively. No patients exhibited any signs of complications such as spinal ischaemia.

conclusionBAE using the triaxial system and NBCA appears to be a useful and safe procedure for haemoptysis. ADVANCES IN KNOWLEDGE: The triaxial system contributes to safe and effective BAE using NBCA.

Indexed as

AgedAged, 80 and overAngiography, Digital SubtractionBronchial ArteriesEmbolization, TherapeuticEnbucrilateFemaleHemoptysisHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeEnbucrilate

Identifiers

PMID26423598
PMCPMC4984931
OpenAlexW1831199187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.